Apyx Medical Corp 8-K

What Happened
On January 12, 2026, Apyx Medical Corporation (APYX) issued a press release reporting its preliminary revenue results for the fourth quarter and the year ended December 31, 2025. The press release is furnished as Exhibit 99.1 to the company’s Form 8‑K (Item 2.02) filed on the same date.

Key Details

• Date of disclosure: January 12, 2026.
• Subject: Preliminary revenue results for Q4 2025 and full year ended December 31, 2025.
• Document: Press release furnished as Exhibit 99.1 to the Form 8‑K.
• Filing reference: Reported under Item 2.02 (Results of Operations and Financial Condition).

Why It Matters
Preliminary revenue figures give investors an early view of the company’s top‑line performance for the quarter and year. These results can influence near‑term investor expectations ahead of any fully audited financial statements, detailed earnings releases, or the company’s annual reports (Form 10‑K). Retail investors should look for the subsequent full financial disclosures for GAAP figures, reconciliations, and additional context.